• 1
    Vadnerkar A, Toyoda Y, Crespo M, et al. Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant 2011; 30: 273281.
  • 2
    Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report–2010. J Heart Lung Transplant 2010; 29: 11041118.
  • 3
    Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001; 33: S58S65.
  • 4
    Lease ED, Zaas DW. Update on infectious complications following lung transplantation. Curr Opin Pulm Med 2011; 17: 206209.
  • 5
    Shields RK, Clancy CJ, Minces LR, et al. Staphylococcus aureus infections in the early period after lung transplantation: Epidemiology, risk factors, and outcomes. J Heart Lung Transplant 2012; 31: 11991206.
  • 6
    Hosseinrezaei H, Rafiei H, Amiri M. Incidence and risk factors of sternal wound infection at site of incision after open-heart surgery. J Wound Care 2012; 21: 408411.
  • 7
    Haley VB, Van Antwerpen C, Tsivitis M, et al. Risk factors for coronary artery bypass graft chest surgical site infections in New York State, 2008. Am J Infect Control 2012; 40: 2228.
  • 8
    Farsky PS, Graner H, Duccini P, et al. Risk factors for sternal wound infections and application of the STS score in coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc 2011; 26: 624629.
  • 9
    Berrios-Torres SI, Mu Y, Edwards JR, Horan TC, Fridkin SK. Improved risk adjustment in public reporting: Coronary artery bypass graft surgical site infections. Infect Control Hosp Epidemiol 2012; 33: 463469.
  • 10
    Thacker J, Toyoda Y. Lung and heart-lung transplantation at University of Pittsburgh: 1982–2009. Clin Transpl 2009: 179195.
  • 11
    Centers for Disease Prevention and Control: Surgical Site Infection (SSI) Event. August, 2011. Procedure-associated Events; Available from:
  • 12
    Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 152S157S.
  • 13
    Mu Y, Edwards JR, Horan TC, Berrios-Torres SI, Fridkin SK. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol 2011; 32: 970986.
  • 14
    Mannien J, Wille JC, Kloek JJ, van Benthem BH. Surveillance and epidemiology of surgical site infections after cardiothoracic surgery in The Netherlands, 2002–2007. J Thorac Cardiovasc Surg 2011; 141: 899904.
  • 15
    Soderquist B. Surgical site infections in cardiac surgery: Microbiology. APMIS 2007; 115: 10081011.
  • 16
    Cristofolini M, Worlitzsch D, Wienke A, Silber RE, Borneff-Lipp M. Surgical site infections after coronary artery bypass graft surgery: Incidence, perioperative hospital stay, readmissions, and revision surgeries. Infection 2012; 40: 397404.
  • 17
    Jonkers D, Elenbaas T, Terporten P, Nieman F, Stobberingh E. Prevalence of 90-days postoperative wound infections after cardiac surgery. Eur J Cardiothorac Surg 2003; 23: 97102.
  • 18
    Sharma M, Berriel-Cass D, Baran J Jr. Sternal surgical-site infection following coronary artery bypass graft: Prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 2004; 25: 468471.
  • 19
    Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery—An updated risk factor analysis in 10 373 consecutive adult patients. Thorac Cardiovasc Surg 2002; 50: 8791.
  • 20
    Wahidi MM, Willner DA, Snyder LD, Hardison JL, Chia JY, Palmer SM. Diagnosis and outcome of early pleural space infection following lung transplantation. Chest 2009; 135: 484491.
  • 21
    Mitsani D, Nguyen MH, Shields RK, et al. Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: Factors impacting levels of and associations between serum troughs, efficacy, and toxicity. Antimicrob Agents Chemother 2012; 56: 23712377.
  • 22
    Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant 2006; 25: 985988.
  • 23
    Braxton JH, Marrin CA, McGrath PD, et al. Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000; 70: 20042007.
  • 24
    Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000; 118: 397402.
  • 25
    Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 2002; 124: 136145.
  • 26
    Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22: 607612.
  • 27
    Shigemura N, Bhama J, Gries CJ, et al. Lung transplantation in patients with prior cardiothoracic surgical procedures. Am J Transplant 2012; 12: 12491255.
  • 28
    Talbot TR. Diabetes mellitus and cardiothoracic surgical site infections. Am J Infect Control 2005; 33: 353359.
  • 29
    Butler SO, Btaiche IF, Alaniz C. Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy 2005; 25: 963976.
  • 30
    Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: A report from the surgical care and outcomes assessment program. Ann Surg 2013; 257: 814.
  • 31
    Richards JE, Kauffmann RM, Zuckerman SL, Obremskey WT, May AK. Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am 2012; 94: 11811186.
  • 32
    Hasse J. Pretransplant obesity: A weighty issue affecting transplant candidacy and outcomes. Nutr Clin Pract 2007; 22: 494504.
  • 33
    Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int 2009; 22: 10411050.
  • 34
    Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: A prospective multivariate time-dependent analysis. J Hepatol 1993; 18: 185195.
  • 35
    Benson AB, Burton JR Jr., Austin GL, et al. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011; 17: 149158.
  • 36
    Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995; 59: 851859.
  • 37
    Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma 2003; 54: 908914.
  • 38
    Talbot TR, D'Agata EM, Brinsko V, Lee B, Speroff T, Schaffner W. Perioperative blood transfusion is predictive of poststernotomy surgical site infection: Marker for morbidity or true immunosuppressant? Clin Infect Dis 2004; 38: 13781382.
  • 39
    Marshall MB, Kohman LJ. Gender and lung transplantation: Size matters, does sex? J Thorac Cardiovasc Surg 2004; 128: 352353.
  • 40
    Bittner HB, Lehmann S, Binner C, Garbade J, Barten M, Mohr FW. Sternum sparing thoracotomy incisions in lung transplantation surgery: A superior technique to the clamshell approach. Innovations (Phila) 2011; 6: 116121.
  • 41
    Shigemura N, Bermudez C, Hattler BG, et al. Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases. J Heart Lung Transplant 2009; 28: 130134.